Study on the clinical efficacy of Mongolian medicine in the treatment of osteoarthritis.
Mongolian medicine
WOMAC pain score
osteoarthritis
randomized contrast
Journal
American journal of translational research
ISSN: 1943-8141
Titre abrégé: Am J Transl Res
Pays: United States
ID NLM: 101493030
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
07
2022
accepted:
03
02
2023
medline:
17
5
2023
pubmed:
17
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
The object of this paper was to evaluate the clinical efficacy and safety of Mongolian medicine in the treatment of osteoarthritis (OA). This was completed by offering evidence to provide a clinical basis for the treatment of OA. We explored the mechanism of the sticking application of Mongolian medicine. A total of 123 patients with OA diagnosed in the Affiliated Hospital of Inner Mongolia Medical University from January 2017 to December 2017 were enrolled. The clinical data of the patients were retrospectively analyzed. Patients were divided into three groups according to the medication they were using at the time: The strapping group, the glucosamine hydrochloride group, and the Mongolian medicine group, with 41 patients in each group. The treatment indicators of the included patients 2 weeks after the treatment and 4 weeks after the treatment were fully recorded in our hospital. The levels of CGRP, TNF-α, MMP-3, VEGF, and IL-10 before and after treatment were measured by ELISA. The auxiliary diagnostic index was X-ray film. Compared with the control group, the Mongolian medicine group improved the symptoms of pain, swelling, limited movement, and daily life quality of patients to different degrees. There was a significant decrease in the VAS score at each time point of the Mongolian medicine group (P < 0.05). tThe scores of bodily pain in SF-36 QOL were significantly higher in the Mongolian medicine group at different time points (P < 0.05). After treatment, the levels of MMP-3, TNF-α, VEGF, and CGRP in the Mongolian medicine group were significantly lower than those before the treatment (P < 0.05). Mongolian medicine can inhibit the expression of MMP-3, TNF-α, VEGF, and CGRP in serum, and up-regulate the trend of IL-10, alleviating the inflammatory reaction. It has a good curative effect in the treatment of OA patients. It is better than western medicine in pain, swelling, and improving bone and joint function index.
Types de publication
Journal Article
Langues
eng
Pagination
2481-2497Informations de copyright
AJTR Copyright © 2023.
Déclaration de conflit d'intérêts
None.
Références
Semin Arthritis Rheum. 2018 Feb;47(4):457-463
pubmed: 28917712
Rev Infirm. 2016 Aug-Sep;223:19-22
pubmed: 27633691
Lancet. 2018 May 19;391(10134):1985
pubmed: 29864015
Am Fam Physician. 2021 Jan 15;103(2):120-121
pubmed: 33448759
J Am Acad Orthop Surg. 2020 Oct 1;28(19):781-789
pubmed: 32986386
Disabil Rehabil. 2018 Dec;40(26):3104-3112
pubmed: 28911242
Ann Rheum Dis. 2014 Sep;73(9):1659-64
pubmed: 23744977
Clin Rehabil. 2022 Mar;36(3):350-358
pubmed: 34658285
Arthritis Care Res (Hoboken). 2021 Jun;73(6):767-769
pubmed: 32166885
Foot Ankle Surg. 2018 Jun;24(3):219-223
pubmed: 29409212
Evid Based Complement Alternat Med. 2021 Nov 18;2021:5233462
pubmed: 34840589
Exp Ther Med. 2021 Jan;21(1):74
pubmed: 33365074
Am J Orthop (Belle Mead NJ). 2017 Nov/Dec;46(6):E358-E365
pubmed: 29309449
Arthritis Res Ther. 2007;9(6):R126
pubmed: 18062805
Zhongguo Gu Shang. 2009 Jun;22(6):428-31
pubmed: 19594039
Osteoarthritis Cartilage. 2022 Sep;30(9):1159-1173
pubmed: 34536529
Aliment Pharmacol Ther. 2009 May 1;29(9):1032-41
pubmed: 19222413
Drugs Aging. 2015 Mar;32(3):179-87
pubmed: 25701074
Br Med Bull. 2013;105:185-99
pubmed: 23337796
J Am Acad Orthop Surg. 2018 Oct 15;26(20):e437-e441
pubmed: 30157057
J Ethnopharmacol. 2020 Jan 30;247:112261
pubmed: 31577939
Cytokine. 2016 Jan;77:211-9
pubmed: 26409848
Medicine (Baltimore). 2021 Mar 26;100(12):e25168
pubmed: 33761693
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S208-28
pubmed: 22588746
Int J Genomics. 2020 Jan 02;2020:5925126
pubmed: 31976312
J Orthop. 2018 Jan 03;15(1):40-46
pubmed: 29326497
Zhongguo Zhen Jiu. 2021 Sep 12;41(9):1010-4
pubmed: 34491651
Evid Based Complement Alternat Med. 2021 Aug 13;2021:3930826
pubmed: 34426743
Comput Biol Chem. 2020 Dec;89:107397
pubmed: 33035753
J Orthop Sci. 2009 May;14(3):348-65
pubmed: 19499305
Pain Med. 2007 Mar;8(2):134-46
pubmed: 17305685
J Orthop Translat. 2020 Oct 21;26:132-140
pubmed: 33437632
Metabolomics. 2020 Apr 25;16(5):61
pubmed: 32335722